Company / Cost of Revenue
CVS Health Cost of Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cost of Revenue
$221.2B
FY2025
5-year range
$158.7B / $221.2B
FY2021-FY2025
Trend
+7.2%
vs FY2024
Sector context
#2 of 113
Health Care
What the data says
Among 113 Health Care companies, CVS Health is in the bottom 2% for cost of revenue. Cost of Revenue has fluctuated over the past 10 years, ranging from $146.5B in FY2016 to $221.2B in FY2025.
Based on SEC 10-K filings.
$221.2B in FY2025 with a 5-year CAGR of +7.2%. Ranks 2nd among 113 companies in Health Care.
Increased from $175.8B to $221.2B over the past 2 years.
Health Care sector context is included.
Cost of Revenue over time
Growth rates
- 3-Year CAGR
- +4.0%
- 5-Year CAGR
- +7.2%
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 113This company $221.2B Sector average $11.3B
▼
+1857.8% above sector average
Key checks
Key Insights
- 5-year CAGR of +7.2%, indicating consistent growth.
- In FY2025, cost of revenue increased 7.2% year-over-year.
- Ranks #2 out of 113 companies in the Health Care sector.
- Lowest cost of revenue in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cost of RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $221.2B | +7.2% |
| FY2024 | $206.3B | +17.3% |
| FY2023 | $175.8B | -10.7% |
| FY2022 | $196.9B | +24.1% |
| FY2021 | $158.7B | +1.5% |
| FY2020 | $156.4B | -1.4% |
| FY2019 | $158.7B | +1.5% |
| FY2018 | $156.4B | +2.0% |
| FY2017 | $153.4B | +4.7% |
| FY2016 | $146.5B | +15.6% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026